Jianfeng Xiao1, Misty M Thompson1, Satya R Vemula1, Mark S LeDoux2. 1. Departments of Neurology, and Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN, USA. 2. Departments of Neurology, and Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN, USA. Electronic address: mledoux@uthsc.edu.
Abstract
BACKGROUND: Isolated blepharospasm (BSP) is a late-onset focal dystonia characterized by involuntary contractions of the orbicularis oculi muscles. Genetic studies of BSP have been limited by the paucity of large multiplex pedigrees. Although sequence variants (SVs) in THAP1 have been reported in rare cases of BSP, the genetic causes of this focal dystonia remain largely unknown. Moreover, in the absence of family history and strong in silico or in vitro evidence of deleteriousness, the pathogenicity of novel SVs in THAP1 and other dystonia-associated genes can be indeterminate. METHODS: A large African-American pedigree with BSP was phenotypically characterized and screened for mutations in THAP1, TOR1A and GNAL with Sanger sequencing. Whole-exome sequencing of the proband was used to examine other dystonia-associated genes for potentially pathogenic SVs. In silico and co-segregation analyses were performed for a novel THAP1 SV identified in the proband. RESULTS: Seven family members exhibited increased blinking and/or stereotyped bilateral and synchronous orbicularis oculi spasms with age of onset ranging from early childhood to late adult life (7 to 54 years). The proband was found to harbor a novel THAP1 SV (c.314T>C, p.L105S). However, the p.L105S SV did not co-segregate with blepharospasm in the pedigree. Moreover, in silico analyses suggest that p.L105S is benign. No pathogenic or likely pathogenic SVs in other dystonia-associated genes were identified with whole-exome sequencing. CONCLUSIONS: Blepharospasm can be familial and may be hereditary in African-Americans. A comprehensive array of in silico tools, and, if possible, co-segregation analysis should be used to classify SVs in dystonia-associated genes.
BACKGROUND: Isolated blepharospasm (BSP) is a late-onset focal dystonia characterized by involuntary contractions of the orbicularis oculi muscles. Genetic studies of BSP have been limited by the paucity of large multiplex pedigrees. Although sequence variants (SVs) in THAP1 have been reported in rare cases of BSP, the genetic causes of this focal dystonia remain largely unknown. Moreover, in the absence of family history and strong in silico or in vitro evidence of deleteriousness, the pathogenicity of novel SVs in THAP1 and other dystonia-associated genes can be indeterminate. METHODS: A large African-American pedigree with BSP was phenotypically characterized and screened for mutations in THAP1, TOR1A and GNAL with Sanger sequencing. Whole-exome sequencing of the proband was used to examine other dystonia-associated genes for potentially pathogenic SVs. In silico and co-segregation analyses were performed for a novel THAP1 SV identified in the proband. RESULTS: Seven family members exhibited increased blinking and/or stereotyped bilateral and synchronous orbicularis oculi spasms with age of onset ranging from early childhood to late adult life (7 to 54 years). The proband was found to harbor a novel THAP1 SV (c.314T>C, p.L105S). However, the p.L105S SV did not co-segregate with blepharospasm in the pedigree. Moreover, in silico analyses suggest that p.L105S is benign. No pathogenic or likely pathogenic SVs in other dystonia-associated genes were identified with whole-exome sequencing. CONCLUSIONS:Blepharospasm can be familial and may be hereditary in African-Americans. A comprehensive array of in silico tools, and, if possible, co-segregation analysis should be used to classify SVs in dystonia-associated genes.
Authors: Mark S LeDoux; Jianfeng Xiao; Monika Rudzińska; Robert W Bastian; Zbigniew K Wszolek; Jay A Van Gerpen; Andreas Puschmann; Dragana Momčilović; Satya R Vemula; Yu Zhao Journal: Parkinsonism Relat Disord Date: 2012-02-28 Impact factor: 4.891
Authors: Michael S Lee; Andrew R Harrison; Daniel S Grossman; Frank A Sloan Journal: Ophthalmic Plast Reconstr Surg Date: 2010 Nov-Dec Impact factor: 1.746
Authors: G Defazio; D Martino; M S Aniello; G Masi; G Abbruzzese; S Lamberti; E M Valente; F Brancati; P Livrea; A Berardelli Journal: J Neurol Neurosurg Psychiatry Date: 2006-02 Impact factor: 10.154
Authors: G Defazio; G Abbruzzese; M S Aniello; M Bloise; C Crisci; R Eleopra; G Fabbrini; P Girlanda; R Liguori; A Macerollo; L Marinelli; D Martino; F Morgante; L Santoro; M Tinazzi; A Berardelli Journal: Neurology Date: 2011-07-20 Impact factor: 9.910
Authors: C Marras; S K Van den Eeden; R D Fross; K S Benedict-Albers; J Klingman; A D Leimpeter; L M Nelson; N Risch; A J Karter; A L Bernstein; C M Tanner Journal: Neurology Date: 2007-08-14 Impact factor: 9.910
Authors: Jianfeng Xiao; Robert W Bastian; Joel S Perlmutter; Brad A Racette; Samer D Tabbal; Morvarid Karimi; Randal C Paniello; Andrew Blitzer; Sat Dev Batish; Zbigniew K Wszolek; Ryan J Uitti; Peter Hedera; David K Simon; Daniel Tarsy; Daniel D Truong; Karen P Frei; Ronald F Pfeiffer; Suzhen Gong; Yu Zhao; Mark S LeDoux Journal: BMC Med Genet Date: 2009-03-11 Impact factor: 2.103
Authors: Jun Tian; Satya R Vemula; Jianfeng Xiao; Enza Maria Valente; Giovanni Defazio; Simona Petrucci; Angelo Fabio Gigante; Monika Rudzińska-Bar; Zbigniew K Wszolek; Kathleen D Kennelly; Ryan J Uitti; Jay A van Gerpen; Peter Hedera; Elizabeth J Trimble; Mark S LeDoux Journal: Mol Genet Genomic Med Date: 2018-05-16 Impact factor: 2.183